Although TCGA consortium has recently confirmed the presence of these two molecular PTC subtypes and that they may be better correlated with molecular signaling and tumor differentiation than histologic subtypes [6], we observed that BRAF-like and RAS-like PTCs had similar recurrence-free survival, as shown in Figure 4. The gene discussed is BRAF; the disease is neoplasm.